PECAM-1 is involved in neutrophil transmigration across Histophilus somni treated bovine brain endothelial cells

Raksha Tiwari1, J Sullivan, C J Czuprynski

  • 1Department of Pathobiological Sciences, University of Wisconsin-Madison, 53706, USA.

Insights

Histophilus somni causes thrombotic meningoencephalitis (TME) in cattle. This study shows platelet endothelial cell adhesion molecule-1 (PECAM-1) and endothelial nitric oxide synthase (eNOS) are involved in TME pathogenesis.

Area of Science:

  • Veterinary Pathology
  • Bacterial Pathogenesis
  • Immunology

Background:

  • Histophilus somni (H. somni) is a significant bacterial pathogen in cattle, responsible for respiratory, reproductive, and central nervous system diseases.
  • Systemic H. somni infections are characterized by vasculitis, which can progress to thrombotic meningoencephalitis (TME), an acute neurological condition.
  • Platelet endothelial cell adhesion molecule-1 (PECAM-1) and endothelial nitric oxide synthase (eNOS) are crucial for maintaining vascular homeostasis.

Purpose of the Study:

  • To investigate the potential role of PECAM-1 and eNOS expression in the pathogenesis of TME caused by H. somni.
  • To understand the molecular mechanisms underlying H. somni-induced vascular damage and neurological disease.

Main Methods:

  • Utilized bovine brain endothelial cells (TBBEC) treated with H. somni.
  • Assessed neutrophil transmigration across endothelial cell monolayers.
  • Employed confocal microscopy to visualize the expression and distribution of PECAM-1 and eNOS.

Main Results:

  • Neutrophil transmigration across H. somni-treated TBBEC was significantly reduced by anti-PECAM-1 antibody treatment.
  • Confocal microscopy revealed that H. somni infection induced a redistribution of PECAM-1 and eNOS on the surface of TBBEC.
  • These molecular changes suggest an interaction between H. somni and endothelial cell surface molecules.

Conclusions:

  • PECAM-1 and eNOS are implicated in the early stages of TME pathogenesis.
  • Targeting PECAM-1 may offer a therapeutic strategy to mitigate H. somni-induced vascular damage.
  • Further research is warranted to elucidate the precise mechanisms of PECAM-1 and eNOS involvement in TME.